Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 76

1.

Identification of and human serum reactogenicity to neutralizing epitopes within the central unglycosylated region of the respiratory syncytial virus attachment protein.

Murata Y, Lightfoote PM, Falsey AR, Walsh EE.

Clin Vaccine Immunol. 2010 Apr;17(4):695-7. doi: 10.1128/CVI.00432-09. Epub 2010 Feb 17.

2.

Humoral response to the central unglycosylated region of the respiratory syncytial virus attachment protein.

Murata Y, Lightfoote PM, Biear JN, Falsey AR, Walsh EE.

Vaccine. 2010 Aug 31;28(38):6242-6. doi: 10.1016/j.vaccine.2010.07.011. Epub 2010 Jul 23.

3.

Antibody response to the central unglycosylated region of the respiratory syncytial virus attachment protein in mice.

Murata Y, Catherman SC.

Vaccine. 2012 Aug 3;30(36):5382-8. doi: 10.1016/j.vaccine.2012.06.016. Epub 2012 Jun 19.

4.

Identification of multiple protective epitopes (protectopes) in the central conserved domain of a prototype human respiratory syncytial virus G protein.

Plotnicky-Gilquin H, Goetsch L, Huss T, Champion T, Beck A, Haeuw JF, Nguyen TN, Bonnefoy JY, Corvaïa N, Power UF.

J Virol. 1999 Jul;73(7):5637-45.

5.

Role of neutralizing antibodies in adults with community-acquired pneumonia by respiratory syncytial virus.

Luchsinger V, Piedra PA, Ruiz M, Zunino E, Martínez MA, Machado C, Fasce R, Ulloa MT, Fink MC, Lara P, Avendaño LF.

Clin Infect Dis. 2012 Apr;54(7):905-12. doi: 10.1093/cid/cir955. Epub 2012 Jan 11.

PMID:
22238168
6.

The first human epitope map of the alphaviral E1 and E2 proteins reveals a new E2 epitope with significant virus neutralizing activity.

Hunt AR, Frederickson S, Maruyama T, Roehrig JT, Blair CD.

PLoS Negl Trop Dis. 2010 Jul 13;4(7):e739. doi: 10.1371/journal.pntd.0000739.

7.

Modification of the respiratory syncytial virus f protein in virus-like particles impacts generation of B cell memory.

Schmidt MR, McGinnes-Cullen LW, Kenward SA, Willems KN, Woodland RT, Morrison TG.

J Virol. 2014 Sep 1;88(17):10165-76. doi: 10.1128/JVI.01250-14. Epub 2014 Jun 25.

8.

[Plasmid construction, expression, immunogenicity and protective efficacy of recombinant protein candidate vaccine of respiratory syncytial virus].

Zeng RH, Gong W, Fang XP, Zhang ZY, Mei XG.

Sheng Wu Gong Cheng Xue Bao. 2005 Jul;21(4):534-9. Chinese.

PMID:
16176088
9.
10.

Antibody-dependent enhancement of respiratory syncytial virus infection by sera from young infants.

Osiowy C, Horne D, Anderson R.

Clin Diagn Lab Immunol. 1994 Nov;1(6):670-7.

11.

Group- and genotype-specific neutralizing antibody responses against respiratory syncytial virus in infants and young children with severe pneumonia.

Sande CJ, Mutunga MN, Medley GF, Cane PA, Nokes DJ.

J Infect Dis. 2013 Feb 1;207(3):489-92. doi: 10.1093/infdis/jis700. Epub 2012 Nov 21.

12.
14.

Development of Electrochemiluminescent Serology Assays to Measure the Humoral Response to Antigens of Respiratory Syncytial Virus.

Maifeld SV, Ro B, Mok H, Chu M, Yu L, Yamagata R, Leonardson T, Chio V, Parhy B, Park S, Carlson M, Machhi S, Ulbrandt N, Falsey AR, Walsh EE, Wang CK, Esser MT, Zuo F.

PLoS One. 2016 Apr 12;11(4):e0153019. doi: 10.1371/journal.pone.0153019. eCollection 2016.

15.

Identification of human neutralizing antibodies that bind to complex epitopes on dengue virions.

de Alwis R, Smith SA, Olivarez NP, Messer WB, Huynh JP, Wahala WM, White LJ, Diamond MS, Baric RS, Crowe JE Jr, de Silva AM.

Proc Natl Acad Sci U S A. 2012 May 8;109(19):7439-44. doi: 10.1073/pnas.1200566109. Epub 2012 Apr 12.

16.

Linear antigenic and immunogenic regions of human respiratory syncytial virus N protein.

Leonov SV, Waris M, Norrby E.

J Gen Virol. 1995 Feb;76 ( Pt 2):357-64.

PMID:
7531217
17.

Evaluation of the live attenuated cpts 248/404 RSV vaccine in combination with a subunit RSV vaccine (PFP-2) in healthy young and older adults.

Gonzalez IM, Karron RA, Eichelberger M, Walsh EE, Delagarza VW, Bennett R, Chanock RM, Murphy BR, Clements-Mann ML, Falsey AR.

Vaccine. 2000 Mar 6;18(17):1763-72.

PMID:
10699324
18.

New neutralizing antibody epitopes in hepatitis C virus envelope glycoproteins are revealed by dissecting peptide recognition profiles.

Kachko A, Kochneva G, Sivolobova G, Grazhdantseva A, Lupan T, Zubkova I, Wells F, Merchlinsky M, Williams O, Watanabe H, Ivanova A, Shvalov A, Loktev V, Netesov S, Major ME.

Vaccine. 2011 Dec 9;30(1):69-77. doi: 10.1016/j.vaccine.2011.10.045. Epub 2011 Oct 29.

PMID:
22041300
20.

Supplemental Content

Support Center